We're here to help.
What information are you looking for?
Join us for a national conversation with researchers, health-care workers, community workers and people with lived experience.
Vascular dementia is one of the more common forms of dementia, but how much do you know about it? Read on to learn more about vascular dementia.
On January 6, 2023, the U.S. Food and Drug Administration approved the new drug Leqembi (also known as lecanemab) for treatment of early Alzheimer’s disease. Here’s what people in Canada might want to know about it.
In the first discussion of Dementia Talks! Canada of 2023, we have an important conversation on how we can all work to improve dementia support nationwide this year.
Hindi, Mandarin and Cantonese are some of the most-spoken languages in Canada. Find essential facts about dementia in multiple languages here.
Our Advisory Group of People with Lived Experience of Dementia is a community of people who guide the Alzheimer Society of Canada. By drawing on their personal stories of living with or supporting people with dementia, our members can share their voices to change how dementia is understood and treated in Canada.
As a person living with dementia, the Charter can help you assert your rights to live free of stigma, benefit from all of Canada's civic and legal rights, participate in policies that affect you and more.